ARCHIVES

Erbitux Plus Chemo Effective For NSCLC; Carboplatin Prevents Testicular Recurrence

This article is from The Cancer Letter archive.

Vol. 31 No. 7 | July 25, 2008

Download PDF Visit The Full Archive

Related Articles

NCI Details How Year 2000 Goals Can Be Reached Bypass Budget Spells Out How Much It Will Cost

June 8, 1984

In Brief: Deisseroth Leaves M.D. Anderson To Head Yale’s Oncology, Gene Therapy Programs

September 15, 1995

Ohio Center Helps Women Stop Smoking, Reduce Cervical Cancer Risk

October 29, 2004

H. Lee Moffitt Cancer Designated A Comprehensive Cancer Center By NCI.

May 4, 2001

ODAC Votes for Marqibo Accelerated Approval

March 30, 2012

Cancer.gov Knocked Offline By Theft Of Routers

July 11, 2003